glp 1 exercise plan Building Muscle While on a GLP-1 Is Hard—But Possible. This Makes It Much Easier Your Guide to Building Muscle

Huang X, Wu M, Lin J, Mou L, Zhang Y, Jiang J

Weight loss timelines Weight loss with GLP-1 medications generally follows a gradual, non-linear path rather than a predictable week-by-week pattern

Clinical Uses Dihydropyridines: Hypertension Angina (stable or variant) Hypertensive emergencies (nicardipine) Subarachnoid hemorrhage (nimodipine) Non-dihydropyridines: Supraventricular arrhythmias (e.g., atrial fibrillation) Angina Hypertension (if no heart failure) Side Effects Dihydropyridines: Headache Flushing Ankle edema Reflex tachycardia Gingival hyperplasia Non-dihydropyridines: Bradycardia AV block Constipation (especially verapamil) Worsening heart failure Contraindications Severe hypotension Heart failure (especially with reduced EF) non-DHPs AV block or sick sinus syndrome Combination of non-DHPs with -blockers (risk of heart block) Drug Interactions Verapamil & diltiazem + -blockers heart block CYP3A4 interactions (e.g., macrolides, statins) To view or add a comment, sign in Modern Retina shared good news for patients with serious retinal disease

[9,32-34] The mechanism of action seems to be promoting cellular glucose uptake by activating an enzyme called adenosine monophosphate kinase (AMPK)

NPI-001 has the potential to treat a broad set of diseases and conditions associated with oxidative stress and reduced glutathione levels such as slowing or stopping disease progression in retinitis pigmentosa patients with functional cones, regardless of their disease-causing genetic mutation

GH and IGF receptors are abundantly expressed in the kidney, including the glomerular and tubular cells